Search research articles
Contact Us
Filters
Showing results (141-150 of 337) with videos related to
Page
of 34
Sort By:
The Journal of Experimental Medicine
|
October 8, 2003
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control
David W Mullins, Stacey L Sheasley, Rebecca M Ream, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2025
Dual targeting OX40 and IL-2 receptor enhances antitumor activity through tumor-infiltrating Treg depletion and CD8<sup>+</sup> T-cell proliferation
Shuaishuai Cao, Zhichen Sun, Wenbo Hu, et al.
Journal of Clinical Medicine
|
January 8, 2023
The Bivalent COVID-19 Booster Immunization after Three Doses of Inactivated Vaccine Augments the Neutralizing Antibody Response against Circulating Omicron Sublineages
Qiaren He, Shiyu Sun, Xi Chen, et al.
The Journal of Clinical Investigation
|
February 21, 2002
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease
Koji Tamada, Hideto Tamura, Dallas Flies, et al.
Science Translational Medicine
|
August 21, 2020
De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection
Daria Beshnova, Jianfeng Ye, Oreoluwa Onabolu, et al.
Cell Discovery
|
May 10, 2022
Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2
Yifan Lin, Jing Sun, Xuezhi Cao, et al.
Nature Communications
|
June 3, 2024
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8<sup>+</sup>T cells for systemic antitumor responses
Zhuangzhi Zou, Jiao Shen, Diyuan Xue, et al.
Nature Cancer
|
April 8, 2022
Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity
Longchao Liu, Jiahui Chen, Hongyi Zhang, et al.
Scientific Reports
|
December 12, 2018
T cell-derived lymphotoxin limits Th1 response during HSV-1 infection
Kaiting Yang, Yong Liang, Zhichen Sun, et al.
The Journal of Experimental Medicine
|
September 27, 2022
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery
Jiao Shen, Zhuangzhi Zou, Jingya Guo, et al.
Page
of 34
Search research articles
Search
Showing results (141-150 of 337) with videos related to
Sort By:
Page
of 34
The Journal of Experimental Medicine
|
October 8, 2003
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control
David W Mullins, Stacey L Sheasley, Rebecca M Ream, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2025
Dual targeting OX40 and IL-2 receptor enhances antitumor activity through tumor-infiltrating Treg depletion and CD8<sup>+</sup> T-cell proliferation
Shuaishuai Cao, Zhichen Sun, Wenbo Hu, et al.
Journal of Clinical Medicine
|
January 8, 2023
The Bivalent COVID-19 Booster Immunization after Three Doses of Inactivated Vaccine Augments the Neutralizing Antibody Response against Circulating Omicron Sublineages
Qiaren He, Shiyu Sun, Xi Chen, et al.
The Journal of Clinical Investigation
|
February 21, 2002
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease
Koji Tamada, Hideto Tamura, Dallas Flies, et al.
Science Translational Medicine
|
August 21, 2020
De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection
Daria Beshnova, Jianfeng Ye, Oreoluwa Onabolu, et al.
Cell Discovery
|
May 10, 2022
Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2
Yifan Lin, Jing Sun, Xuezhi Cao, et al.
Nature Communications
|
June 3, 2024
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8<sup>+</sup>T cells for systemic antitumor responses
Zhuangzhi Zou, Jiao Shen, Diyuan Xue, et al.
Nature Cancer
|
April 8, 2022
Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity
Longchao Liu, Jiahui Chen, Hongyi Zhang, et al.
Scientific Reports
|
December 12, 2018
T cell-derived lymphotoxin limits Th1 response during HSV-1 infection
Kaiting Yang, Yong Liang, Zhichen Sun, et al.
The Journal of Experimental Medicine
|
September 27, 2022
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery
Jiao Shen, Zhuangzhi Zou, Jingya Guo, et al.
Page
of 34